Stock Scorecard



Stock Summary for Galapagos NV (GLPG) - $31.67 as of 8/13/2025 3:26:22 PM EST

Total Score

11 out of 30

Safety Score

40 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for GLPG

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GLPG

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GLPG

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for GLPG

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for GLPG (40 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for GLPG

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy ( RMAT ) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma 8/6/2025 5:30:00 AM
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy ( RMAT ) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma - Galapagos ( NASDAQ:GLPG ) 8/6/2025 5:30:00 AM
SET SAIL ON A VACATION THAT NOTHING COMES CLOSE TO, AS CELEBRITY CRUISES REVEALS THE FIRST OF ITS 2027-2028 ITINERARIES - Royal Caribbean Gr ( NYSE:RCL ) 8/5/2025 1:31:00 PM
Lindblad Q2 Revenue Jumps 23% 8/4/2025 4:28:00 PM
A SEASON OF DISCOVERY: NATIONAL GEOGRAPHIC-LINDBLAD EXPEDITIONS UNVEILS 2027-28 DEPLOYMENT 7/30/2025 1:40:00 PM
Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Community Health Sys ( NYSE:CYH ) , Chipotle Mexican Grill ( NYSE:CMG ) 7/24/2025 12:36:00 PM
Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - American Eagle Outfitters ( NYSE:AEO ) , Chipotle Mexican Grill ( NYSE:CMG ) 7/24/2025 9:23:00 AM
e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data 7/10/2025 12:00:00 PM
GOVERNMENT OF CANADA EXTENDS MDA SPACE CONTRACT PROVIDING CONTINUOUS SPACE-BASED MARITIME AWARENESS AND SECURITY 6/30/2025 12:15:00 PM
Galapagos Appoints Aaron Cox as Chief Financial Officer 6/23/2025 5:30:00 AM

Financial Details for GLPG

Company Overview

Ticker GLPG
Company Name Galapagos NV
Country USA
Description Galapagos NV, a clinical-stage biotechnology company, discovers, develops and markets several small molecule drugs. The company is headquartered in Mechelen, Belgium.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 31.67
Price 4 Years Ago 55.13
Last Day Price Updated 8/13/2025 3:26:22 PM EST
Last Day Volume 293,547
Average Daily Volume 343,263
52-Week High 33.86
52-Week Low 22.36
Last Price to 52 Week Low 41.64%

Valuation Measures

Trailing PE N/A
Industry PE 43.11
Sector PE 57.42
5-Year Average PE -3.02
Free Cash Flow Ratio 29.06
Industry Free Cash Flow Ratio 16.50
Sector Free Cash Flow Ratio 30.31
Current Ratio Most Recent Quarter 8.08
Total Cash Per Share 1.09
Book Value Per Share Most Recent Quarter 40.12
Price to Book Ratio 0.68
Industry Price to Book Ratio 34.22
Sector Price to Book Ratio 28.40
Price to Sales Ratio Twelve Trailing Months 7.61
Industry Price to Sales Ratio Twelve Trailing Months 107.50
Sector Price to Sales Ratio Twelve Trailing Months 32.19
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 65,897,000
Market Capitalization 2,086,957,990
Institutional Ownership 22.17%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 74.80%
Annual Earnings Growth -65.01%
Reported EPS 12 Trailing Months -5.10
Reported EPS Past Year -4.30
Reported EPS Prior Year 1.01
Net Income Twelve Trailing Months -284,274,000
Net Income Past Year 74,082,000
Net Income Prior Year 211,697,000
Quarterly Revenue Growth YOY -16.20%
5-Year Revenue Growth -20.07%
Operating Margin Twelve Trailing Months -87.40%

Balance Sheet

Total Cash Most Recent Quarter 71,669,000
Total Cash Past Year 64,239,000
Total Cash Prior Year 166,803,000
Net Cash Position Most Recent Quarter 71,669,000
Net Cash Position Past Year 64,239,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 2,896,939,000
Total Stockholder Equity Prior Year 2,795,566,000
Total Stockholder Equity Most Recent Quarter 2,643,819,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -297,684,000
Free Cash Flow Per Share Twelve Trailing Months -4.52
Free Cash Flow Past Year -402,136,000
Free Cash Flow Prior Year -425,243,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.91
MACD Signal 1.01
20-Day Bollinger Lower Band 23.05
20-Day Bollinger Middle Band 28.44
20-Day Bollinger Upper Band 33.82
Beta -0.05
RSI 53.14
50-Day SMA 27.54
150-Day SMA 33.81
200-Day SMA 39.40

System

Modified 8/14/2025 12:45:47 AM EST